by Admin | Jun 12, 2017 | Bioethics, News & Opinions, Policy
I just spent a week at Wake Forest University Institute for Regenerative Medicine. I enjoyed the experience of being immersed in all things tissue-regeneration, bio-printing, scaffold development, and, especially, the unique collaboration model they have with private...
by Bernard Siegel | Jun 6, 2017 | News & Opinions, Science
On December 2016, Mayor Bill De Blasio announced that the city’s next great industry is biotechnology. A lofty goal grounded in reality and backed with a $500 million funding commitment. Not long after this announcement, in April 2017, I visited New York to witness...
by Bernard Siegel | May 25, 2017 | News & Opinions, Policy
In December 2015, the Bipartisan Policy Center –a Washington, D.C. nonprofit think-tank– published a seminal paper entitled Advancing Regenerative Cellular Therapy -Medical Innovation Healthier Americans. This Report provided information about the nature of cell...
by Bernard Siegel | May 23, 2017 | News & Opinions, Science
Twelve years ago my nonprofit organization founded an annual conference that evolved into the World Stem Cell Summit. Over time, this event has brought together thousands of thought leaders and stakeholders from around the globe. All came with a shared passion, to...
by Admin | May 18, 2017 | News & Opinions, Science
Stem cells have been lauded for their potential to cure a large array of cell based conditions, from muscular dystrophy to cancer to Parkinson’s Disease. But they have another, lesser known use: as tools for research into how human cells respond to an almost limitless...
by Admin | May 17, 2017 | News & Opinions
What happens when a cell-based therapy gets characterized as a “cure”? A Patient’s Answer May Be Surprising. How is using the word “cure” at this stage of our clinical translation of regenerative medicine likely to impact patients the most? I’ve considered...
